APA (7th ed.) Citation

LC, S., J, M., A, L., F, K., F, J., K, G., . . . M, G. (2021). Safety of axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma in an elderly intercity population. Bone marrow transplantation, 56(7), 1761. https://doi.org/10.1038/s41409-021-01280-3

Chicago Style (17th ed.) Citation

LC, Shapiro, et al. "Safety of Axicabtagene Ciloleucel for Relapsed/refractory Large B-cell Lymphoma in an Elderly Intercity Population." Bone Marrow Transplantation 56, no. 7 (2021): 1761. https://doi.org/10.1038/s41409-021-01280-3.

MLA (9th ed.) Citation

LC, Shapiro, et al. "Safety of Axicabtagene Ciloleucel for Relapsed/refractory Large B-cell Lymphoma in an Elderly Intercity Population." Bone Marrow Transplantation, vol. 56, no. 7, 2021, p. 1761, https://doi.org/10.1038/s41409-021-01280-3.